Steroid avoidance in liver transplantation

被引:2
|
作者
Oberholzer, Jose [1 ]
Al-Saghier, Mohammed [1 ]
Kneteman, Norman M. [1 ]
机构
[1] Univ Alberta, Edmonton, AB, Canada
关键词
Immunosuppression; Liver transplantation; Mycophenolate mofetil; Steroids;
D O I
10.1155/2004/412135
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Corticosteroids have always played a Valuable role in transplantation. Unfortunately, they are Subject to a wide range of side effects, such as hyperlipidemia, hypertension, diabetes mellitus, osteoporosis, growth retardation and Cushingoid appearance. Steroids may also exacerbate problems that existed before Surgery, including malignancy, hepatitis B and hepatitis C. New, powerful immunosuppressants have allowed steroid use to be reduced or avoided altogether, but use of these regimens is not simple and may be associated with late acute rejection and recurrence of autoimmune disease. The present review examines the rationale for steroid avoidance in liver transplantation and assesses the new regimens that are currently being developed.
引用
收藏
页码:5C / 11C
页数:7
相关论文
共 50 条
  • [31] Steroid-free living-donor liver transplantation in adults
    Marubashi, S
    Dono, K
    Amano, K
    Hama, N
    Gotoh, K
    Takahashi, H
    Hashimoto, K
    Miyamoto, A
    Takeda, Y
    Nagano, H
    Umeshita, K
    Monden, M
    TRANSPLANTATION, 2005, 80 (05) : 704 - 706
  • [32] Immunosuppression in Liver Transplantation: Renoprotective Regimens
    Serrano Aullo, M. Trinidad
    Parra Moncasi, Eduardo
    Lorente Perez, Sara
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2011, 34 (06): : 422 - 427
  • [33] Current immunosuppressive approaches in liver transplantation
    Iacob, S.
    Cicinnati, V. R.
    Beckebaum, S.
    PANMINERVA MEDICA, 2009, 51 (04) : 215 - 225
  • [34] Selection and use of immunosuppressive therapies after liver transplantation: current German practice
    Herzer, Kerstin
    Strassburg, Christian P.
    Braun, Felix
    Engelmann, Cornelius
    Guba, Markus
    Lehner, Frank
    Nadalin, Silvio
    Pascher, Andreas
    Scherer, Marcus N.
    Schnitzbauer, Andreas A.
    Zimmermann, Tim
    Nashan, Bjoern
    Sterneck, Martina
    CLINICAL TRANSPLANTATION, 2016, 30 (05) : 487 - 501
  • [35] Indications of mycophenolate mofetil in liver transplantation
    Klupp, J
    Pfitzmann, R
    Langrehr, JM
    Neuhaus, P
    TRANSPLANTATION, 2005, 80 (01) : S142 - S146
  • [36] Outcome and Prognostic Factors of Liver Transplantation in Cryptogenic Liver Cirrhosis
    Sivandzadeh, G. R.
    Ejtehadi, F.
    Shamsaeefar, A. R.
    Beheshti, M.
    INTERNATIONAL JOURNAL OF ORGAN TRANSPLANTATION MEDICINE, 2023, 14 (04): : 17 - 26
  • [37] Basics and Art of Immunosuppression in Liver Transplantation
    Poudel, Shekhar
    Gupta, Subhash
    Saigal, Sanjiv
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2024, 14 (03)
  • [38] Optimizing use of basiliximab in liver transplantation
    Ramirez, Carlo B.
    Bozdin, Adam
    Frank, Adam
    Maley, Warren
    Doria, Cataldo
    TRANSPLANT RESEARCH AND RISK MANAGEMENT, 2010, 2 : 1 - 10
  • [39] Completely steroid-free immunosuppression in liver transplantation: a randomized study
    Ramirez, Carlo B.
    Doria, Cataldo
    Frank, Adam M.
    Armenti, Stephen T.
    Marino, Ignazio R.
    CLINICAL TRANSPLANTATION, 2013, 27 (03) : 463 - 471
  • [40] Renal transplantation with early steroid withdrawal
    Schiff, Jeffrey
    Cole, Edward H.
    PEDIATRIC NEPHROLOGY, 2009, 24 (02) : 243 - 251